A case of dengue fever after chemotherapy for lung adenocarcinoma
Yuki Chikoa Daisuke Morichikab Mizuho Matsushitac Yuka Beikab Eiki Ichiharad Toshiaki Okadab
aDepartment of Internal Medicine, Independent Administrative Agency, National Hospital Organization, Fukuyama Medical Center
bDepartment of Respiratory Medicine, Independent Administrative Agency, National Hospital Organization, Fukuyama Medical Center
cDepartment of Respiratory Medicine, Tottori Prefectural Central Hospital
dDepartment of Allergy and Respiratory Medicine, Okayama University Hospital
We report a case of dengue fever with leukopenia and fever that developed during chemotherapy. A male in his fifties presented with fever and chills nine days after his return to Japan from a three-month stay in Myanmar. He underwent chemotherapy for advanced lung adenocarcinoma cancer three days before visiting our hospital. Imported infectious diseases, as well as febrile neutropenia due to chemotherapy, were considered because of fever-accompanied skin rash and cytopenia. He was diagnosed with dengue fever via a positive dengue NS1 antigen test. In a patient with a history of travel to an area at risk of dengue fever who develops fever and skin rash even during chemotherapy, imported infectious diseases such as dengue fever should be distinguished.
Lung cancer Dengue fever Febrile neutropenia Bevacizumab Imported infectious disease
Received 20 Jan 2022 / Accepted 14 Apr 2022
AJRS, 11(4): 188-192, 2022